BioSpace News Archive

Henry Schein, Inc. announced that the Company will present at the following investor conferences in June: Stifel 2022 Annual Dental & Veterinary Conference on June 1, 2022, at 10:55 a.m. Eastern time.

Karuna Therapeutics, Inc. announced that it will host a virtual event on Wednesday, May 25, 2022, at 8:00 a.m. ET.

Labcorp announced the receipt of Emergency Use Authorization from the U.S. Food and Drug Administration for a combined at-home collection kit available that simultaneously detects COVID-19, influenza A/B and respiratory syncytial virus, a common but contagious respiratory virus often seen in children.

Albany NY, United States: Transparency Market Research has published a new report titled, ‘Clinical Laboratory Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

Albany NY, United States: The global mHealth services market was valued at US$ 111.6 Bn in 2021 and is projected to expand at a CAGR of 15.7% from 2022 to 2031.

Albany NY, United States: The increasing presence of vast telemedicine providers is projected to add a boost to the growth of the global telemedicine market.

Albany NY, United States: According to Transparency Market Research’s latest research report on the global ligation devices market for the historical period and the forecast period, increase in the number of minimally invasive surgical procedures performed is anticipated to drive the global ligation devices market in the near future

Lysogene, a phase 3 gene therapy platform company targeting central nervous system diseases, provided updated clinical data from the ongoing AAVance phase 2/3 clinical trial with the investigational gene therapy LYS-SAF302 for the treatment of MPS IIIA during the 25th Annual Meeting of the ASGCT in Washington, DC.

Keros Therapeutics, Inc. announced preliminary topline results from Part 1 of its Phase 1 clinical trial evaluating single and multiple ascending doses of KER-012 in healthy postmenopausal volunteers.

Ambys Medicines, a company pioneering cell-replacement therapies for patients with liver disease, announced new data on its universal hepatocyte program in an oral presentation at the American Society of Gene and Cell Therapy 25th Annual Meeting at 3:45 p.m. ET.